Efficacy and safety of fludarabine and cyclophosphamide combined therapy in patients with refractory/recurrent B-cell chronic lymphocytic leukaemia (B-CLL) - Polish multicentre study

Leukemia and Lymphoma

Volumn 45, Issue 6, 2004, Pages 1159-1165

  Kowal, M ^a   Dmoszynska A ^a   Lewandowski, K ^b   Hellmann, A ^b   Wegrzyn J ^c   Skotnicki, A B ^c   Wolowiec D ^d   Kuliczkowski, K ^d   Piszcz, J ^e   Kloczko J ^e   Roznowski, K ^f   Komarnicki, M ^f  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d WROCLAW MEDICAL UNIVERSITY   (Poland)

^e Medica Academy in Bia ystok   (Poland)

^f POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

CLL; Cyclophosphamide; Efficacy; Fludarabine; Toxicity

Indexed keywords

AMINOTRANSFERASE; CHLORAMBUCIL; CLADRIBINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; MITOXANTRONE; PREDNISONE; VINBLASTINE; VINCRISTINE;

ADULT; AGED; ANEMIA; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; AUTOIMMUNE HEMOLYTIC ANEMIA; B CELL LEUKEMIA; BACTERIAL INFECTION; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CANDIDA; CANDIDIASIS; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EOSINOPHILIA; FEMALE; FOLLOW UP; HERPES SIMPLEX VIRUS; HUMAN; INFECTION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; NEUTROPENIA; PHLEBITIS; PNEUMOCYSTIS CARINII; POLAND; POLYNEUROPATHY; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; SKIN ALLERGY; THROMBOCYTOPENIA; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLAND; SAFETY; SURVIVAL RATE; TREATMENT OUTCOME; VIDARABINE;

EID: 2342467322     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190310001624152     Document Type: Article

References (25)

1. Cheson, B.D. (1998) "New prospects in the treatment of indolent lymphomas with purine analogues", Cancer Journal of Scientific American 4 (suppl. 2), S27-36.
2. Bellosillo, B., Villamor, N., Colomer D., et al. (1999) "In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic: leukemia", Blood, 94, 2836-2843.
3. Cheson, B.D., Bennett, J.M., Grever, M., et al. (1996) "National Cancer Institute-Sponsored Working Group guidelines for diagnosis and treatment", Blood, 87, 4990-4997
4. Keating, M.J. (1999) "Chronic lymphocytic leukemia", Seminars in Oncology, 26(5 suppl 14), 107-114.
5. CLL Trialists' Collaborative Group (1999) "Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials", Journal of National Cancer Institute, 91, 861-868.
6. O'Brien, S., Kantarjian, H.M., Cortes, J., et al. (2001) "Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia", Journal of Clinical Oncology, 19, 1414-1420.
7. Robak, T., Błasinska-Morawiec, M., Krykowski, E., et al. (1996) "Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia", Leukemia and Lymphoma, 22, 509-514.
8. Leporrier, M., Chevret, S., Cazin, B., et al. (2001) "For the French Cooperative Group on Chronic Lymphocytic Leukemia. Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients", Blood, 98, 2319-2325.
9. Hallek, M., Schmitt, B., Wilhelm, M., et al. (2001) "Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group". British Journal of Haematology 114, 342-348.
10. Bosanquet, A.G., Johnson, S.A. and Richards, S.M. (1999) "Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay", British Journal of Haematology, 106, 71-77
11. Frewin, R., Turner, D., Tighe, M., et al. (1999) "Combination therapy with fludarabine and cyclophosphamide as salvage treatment in lymphoproliferative disorders". British Journal of Haematology, 104, 612-613.
12. Keating, M.J., O'Brien, S., Lerner, S., et al. (1998) "Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy". Blood, 92, 1165-1171.
13. Bosch, F., Ferrer, A., Lopez-Guillermo, A., et al. (2002) "Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia", British Journal of Haematology, 119, 976-984.
14. Montillo, M., Tedeschi, A., O'Brien, S., et al. (2003) "Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia". Cancer, 97, 114-120.
15. Robak, T., Błoński, J.Z., Kasznicki, M., et al. (2002) "Re-treatment with cladribine - based regimens in relapsed patients with B-cell chronic lymphocytic leukemia. Efficacy and toxicity in comparison with previous treatment", European Journal of Haematology, 69, 27-36.
16. Robak, T., Błoński, J.Z., Kasznicki, M., et al. (2002) "Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymohocytic leukemia". The Hematology Journal, 3(suppl.1), 247, abs.824.
17. Perkins, J.G., Flynn, J.M., Howard, R.S. and Byrd, J.C. (2002) "Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: Implications for clinical trials in this population". Cancer, 94, 2033-2039.
18. Kowal, M., Dmoszynska, A., Koktysz, M. and Mańko, J. (1999) "Infectious complications during 2-chlorodeoxyadenosine therapy". Ann. Univ. M. Curie-Skłodowska, LIV, 75-83.
19. Hamblin, T. (2001) "Autoimmune disease and its management in chronic lymphocytic leukemia. In Chronic lymphoid leukemias, edited by B.D. Cheson. Pp. 435-458. New York: Marcel Dekker, Inc.
20. Johnson, S., Smith, A.G., Loffler, H., et al. For French Cooperative Group on CLL. (1996) "Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicine, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukemia". Lancet, 347, 1432-1438.
21. Robak, T., Błoński, J.Z., Kasznicki, M., et al. (2000) "Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial". Blood, 96, 2723-2729
22. Keating, M.J., Kantarjian, H., Talpaz, M., et al. (1989) "Fludarabine: a new agent with major activity against chronic lymphocytic leukemia", Blood, 74, 19-25.
23. Boogaerts, M. (2000) New options for first- and second-line CLL treatment. Satellite symposium Schering AG:Haematological malignancies-latest advances and future directions. EHA, Birmingham, June 2000.
24. Lauria, F., Rondelli, D., Raspadori, D., et al. (1994) "Rapid restoration of natural killer activity following treatment with 2-chlorodeoxyadenosine in 22 patients with hairy-cell leukemia" . European Journal of Haematology, 52, 16-20.
25. Dmoszyńska, A., Legieć, W. and Wach, M. (1999) "Attempted reconstruction of the immune system using low dose of interleukin 2 in chronic lymphocytic leukemia patients treated with 2-chlorodeoxyadenosine: results of a pilot study". Leukemia and Lymphoma, 34, 335-340.